DR. MATTHEW BLAKE LOCKWOOD MD NPI 1265875470

NPI Details

DR. Matthew Blake Lockwood, MD is a hematology and oncology internal medicine in Fayetteville, AR with 13 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Matthew Blake Lockwood, MD NPI is 1265875470. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF ARKANSAS COLLEGE OF MEDICINE
Graduation Year:2013

The provider's business location address is:

3232 N NORTHHILLS BLVD
FAYETTEVILLE, AR
ZIP 72703-005
Phone: (479) 587-1700
Fax: (479) 587-1366

The NPI 1265875470 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
• Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
• Injection, gadoterate meglumine, 0.1 ml (HCPCS:A9575)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, nivolumab, 1 mg (HCPCS:J9299)
• Injection, testosterone cypionate, 1 mg (HCPCS:J1071)
• Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS:J9144)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram (HCPCS:Q5110)
• Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1561)
• Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
• Injection, bortezomib (velcade), 0.1 mg (HCPCS:J9041)
• Injection, fosaprepitant, 1 mg (HCPCS:J1453)
• Injection, iron sucrose, 1 mg (HCPCS:J1756)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, docetaxel, 1 mg (HCPCS:J9171)
• Injection, rituximab-abbs, biosimilar, (truxima), 10 mg (HCPCS:Q5115)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Magnesium level (HCPCS:83735)
• Phosphate level (HCPCS:84100)
• Uric acid level, blood (HCPCS:84550)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Bilirubin level, direct (HCPCS:82248)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg (HCPCS:Q5107)
• Injection, atropine sulfate, 0.01 mg (HCPCS:J0461)
• Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Injection, etoposide, 10 mg (HCPCS:J9181)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Measurement of substance using immunoassay technique (HCPCS:83520)
• Injection, irinotecan, 20 mg (HCPCS:J9206)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Ferritin (blood protein) level (HCPCS:82728)
• Cyclophosphamide, 100 mg (HCPCS:J9070)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
• Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
• Unclassified drugs (HCPCS:J3490)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Ct scan of chest with contrast (HCPCS:71260)
• Injection, doxorubicin hydrochloride, 10 mg (HCPCS:J9000)
• Ct scan of abdomen and pelvis before and after contrast (HCPCS:74178)
• Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Folic acid level, serum (HCPCS:82746)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Manual urinalysis test with examination using microscope, non-automated (HCPCS:81000)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99439)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Blood creatinine level (HCPCS:82565)
• Piflufolastat f-18, diagnostic, 1 millicurie (HCPCS:A9595)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Thyroxine (thyroid chemical), total (HCPCS:84436)
• Injection, midazolam hydrochloride, per 1 mg (HCPCS:J2250)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Blood test, clotting time (HCPCS:85610)
• Cortisol (hormone) measurement, total (HCPCS:82533)
• Injection, furosemide, up to 20 mg (HCPCS:J1940)
• Administration of prolonged chemotherapy into vein (HCPCS:96416)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
• Glutamyltransferase (liver enzyme) level (HCPCS:82977)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)
• X-ray of chest, 2 views (HCPCS:71046)
• Ct scan of chest without contrast (HCPCS:71250)
• Fee covid-19 vac 14 res (HCPCS:0134A)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Injection of drug or substance into vein (HCPCS:96374)
• Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) (HCPCS:G0506)
• Drawing of blood for a medical problem (HCPCS:99195)
• Hospital discharge day management, 30 minutes or less (HCPCS:99238)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Mri scan of brain before and after contrast (HCPCS:70553)
• Nuclear medicine study whole body with ct scan (HCPCS:78816)
• Vitamin d-3 level (HCPCS:82306)
• Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
• Administration of chemotherapy into vein using push technique (HCPCS:96409)
• Injection, meperidine hydrochloride, per 100 mg (HCPCS:J2175)
• Mri scan of abdomen before and after contrast (HCPCS:74183)
• Mri scan of pelvis before and after contrast (HCPCS:72197)
• Limited ultrasound scan of abdomen (HCPCS:76705)
• Biopsy and aspiration of bone marrow sample for diagnosis (HCPCS:38222)
• Remote therapeutic monitoring treatment management services by physician or other qualified health care professional, first 20 minutes per calendar month (HCPCS:98980)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 125 (HCPCS:86304)
• Adm sarscov2 30mcg/0.3ml bst (HCPCS:0004A)
• Transitional care management services for problem of high complexity (HCPCS:99496)
• Ct scan of soft tissue of neck with contrast (HCPCS:70491)
• Red blood count, automated test (HCPCS:85045)
• Ultrasound study of one arm or leg veins with compression and maneuvers (HCPCS:93971)
• Heart muscle strain imaging (HCPCS:93356)
• Adm sarscov2 30mcg/0.3ml 3rd (HCPCS:0003A)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)

The enumeration date for this NPI number is 4/8/2013 and was last updated on 1/31/2024.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.